T cell stemness and dysfunction in tumors are triggered by a common mechanism
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Stemness against adversity T lymphocytes are powerful immune cells that can destroy tumors, but cancers have developed tricks to evade killing. Vodnala et al. found that potassium ions in the tumor microenvironment serve a dual role of influencing T cell effector function and stemness (see the Perspective by Baixauli Celda et al. ). Increased potassium impairs T cell metabolism and nutrient uptake, resulting in a starvation state known as autophagy. The increased potassium can also preserve T cells in a stem-like state where they retain the capacity to divide. These seemingly divergent processes are linked to the cellular distribution of acetyl–coenzyme A, which, when manipulated, can restore the ability of human T cells to eliminate tumors in mice. Science , this issue p. eaau0135 ; see also p. 1395
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Disabled autophagy due to progressive depletion of spermidine in aging tissues 233 can be expected to interfere with the immune recognition of cancer cells due the incapacity of dendritic cells to recognize autophagy-deficient cancer cells, as well as due to defective T lymphocyte and NK cell responses.163,252”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [163]
Experimental — accuracy not yet measuredIn the citing paper
“This relies on cancer cell-autonomous effects but may also involve the autophagy-driven maintenance of a functional T cell memory stem cell pool, hence avoiding the exhaustion of the anticancer immune response.163”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [163]
In the citing paper
“In addition, the extracellular release of potassium by dying cancer cells leads to the induction of autophagy in CD8+ T cells, thus resulting in the acquisition of a stem cell‐like phenotype and ultimately improving tumor clearance.”
From Autophagy in major human diseases (2021) · cites this paper as Vodnala et al, 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 4,330
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823 · cited 2×
“For example, TILs can be expanded ex vivo (>10(10) cells) and readministered to cancer patients, resulting in clonal repopulation and the durable destruction of large metastatic solid tumors (2, 3).”
BackgroundSelf-citationAdoptive cell transfer as personalized immunotherapy for human cancer
Rosenberg, S. A., & Restifo, N. P. (2015) · Science · doi:10.1126/science.aaa4967 · Cited by 2,506 · cited 1×
“Nonetheless, the T cells of some patients maintain the capacity to proliferate, persist, and mediate the complete destruction of large tumor deposits (1).”
BackgroundSelf-citationRosenberg, S. A., Yang, J. C., Sherry, R. M., Kammula, U. S., Hughes, M. S., Phan, G. Q., Citrin, D. E., Restifo, N. P., Robbins, P. F., Wunderlich, J. R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0116 · Cited by 2,140 · cited 1×
“For example, TILs can be expanded ex vivo (>10(10) cells) and readministered to cancer patients, resulting in clonal repopulation and the durable destruction of large metastatic solid tumors (2, 3).”
BackgroundSelf-citationDefining CD8+ T cells that provide the proliferative burst after PD-1 therapy
Im, S. J., Hashimoto, M., Gerner, M. Y., Lee, J., Kissick, H. T., Burger, M. C., Shan, Q., Hale, J. S., Lee, J., Nasti, T. H., et al. (2016) · Nature · doi:10.1038/nature19330 · Cited by 2,070 · cited 1×
“GSEA revealed that ↑[K]e conditioning resulted in a transcriptional profile that parallels the subset of CD8 T cells recently identified as retaining stemness and the capacity to respond to PD-1 therapy in the setting of chronic antigen exposure (15) (Fig.”
BackgroundDefining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Sade-Feldman, M., Yizhak, K., Bjorgaard, S. L., Ray, J. P., de Boer, C. G., Jenkins, R. W., Lieb, D. J., Chen, J. H., Frederick, D. T., Barzily-Rokni, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.038 · Cited by 2,053 · cited 6×
“We and others have previously identified the transcription factor Tcf7 as being critically involved in the retention of stemcell–like attributes in antigen-experienced T cells (9, 11).”
BackgroundInfluential
Research works printed but not linked: 1
- H. Lodish A. Berk S. Zipursky in Molecular Cell Biology 4th Edition (2000) pp. 1–5.
Cited by
Items 401–500 of 559
Targeting autophagy to enhance cancer immunotherapy: emerging mechanisms and strategies
Almutairi, J. A. (2025) · Medical Oncology · doi:10.1007/s12032-025-03081-w · Cited by 6
“However, single-cell RNA sequencing has demonstrated a lack of concordance between the autophagy flux of tumor cells (LC3B-II/LC3B-I ratio) and the autophagy states of immune cells within the TME, which has complicated the presented findings [144, 145].”
Xie, J., Wang, S., Zhao, H., Wang, J., Liu, J., Wei, R., Wang, X., & Li, Y. (2026) · Nano Today · doi:10.1016/j.nantod.2025.102967 · Cited by 7
Wu, Y., Tian, L., Pugel, A., Alimohammadi, R., Cheng, Q., Cui, W., Nishimura, M. I., Ball, L. E., Lin, C.-W., Mehrotra, S., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci192928 · Cited by 6
“High potassium concentration in the TME induces autophagy in TILs and limits their effector function but preserves stemness (60).”
Xu, Z., Li, Z. Z., Deng, Z., Ding, C., Wu, J., Zhang, C., Wei, H., He, T., Long, L., Tang, L., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-01902-2 · Cited by 7
Metabolic control of epigenetic rearrangements in B cell pathophysiology
Calciolari, B., Scarpinello, G., Tubi, L. Q., Piazza, F., & Carrer, A. (2022) · Open Biology · doi:10.1098/rsob.220038 · Cited by 8
Luo, Y., Luo, J., Yang, M. J., & Zhao, X. (2025) · Oncology Letters · doi:10.3892/ol.2025.15201 · Cited by 6
“Conversely, higher K + levels can enhance T cell stemness, maintaining their undifferentiated state (52).”
Zhang, Z., Du, N., He, G., Zhang, M., Zhang, G., Gao, J., Liu, Y., Deng, Y., Sun, L., & Li, M. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.114791 · Cited by 6
Targeting T cell metabolism for immunotherapy
Gao, J., Liu, Y., Wei, J., Jiang, L., Mao, J., Chang, C.-H., & Wu, D. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr0921-011r · Cited by 6
Ren, H., Zheng, J., Cheng, Q., Yang, X., & Fu, Q. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.900713 · Cited by 7
“In melanoma, a high level of potassiumwas released from the necrotic tumor cell, which inhibits CD4 and CD8 T-cell activities, resulting in the blockade of antitumor immunity (Vodnala et al., 2019).”
BackgroundTumor evolution-targeted nanomedicineEVT
Zhang, L., Yang, J., Tang, D., Zhang, H., Ding, J., & Xiao, H. (2022) · Scientia Sinica Chimica · doi:10.1360/ssc-2022-0158 · Cited by 7
Necroptosis in the sarcoma immune microenvironment: From biology to therapy
Ye, H., Lu, M., Tu, C., & Li, M. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110603 · Cited by 6
Gong, H., Nie, D., & Li, Z. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114410 · Cited by 6
Machado, A., Pouzolles, M., Gailhac, S., Fritz, V., Craveiro, M., López-Sánchez, U., Kondo, T., Pala, F., Bosticardo, M., Notarangelo, L. D., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01562 · Cited by 6
“Indeed, the uptake of calcium (25–27) and iron (28) have long been known to be critical for T cell differentiation and more recently, potassium has been shown to regulate the effector function of T lymphocytes (29, 30).”
BackgroundRegulating the discriminatory response to antigen by T-cell receptor
Gangopadhyay, K., Roy, S., Gupta, S. S., Chandradasan, A. C., Chowdhury, S., & Das, R. (2022) · Bioscience Reports · doi:10.1042/bsr20212012 · Cited by 6
Fasting and cancer responses to therapy
Pedro, J. M. B., & Pietrocola, F. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.08.002 · Cited by 6
Li, J., Xu, Y., Peng, G., Zhu, K., Wu, Z., Shi, L., & Wu, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.788671 · Cited by 6
A brief glimpse of a tangled web in a small world: Tumor microenvironment
Talaat, I. M., & Kim, B. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1002715 · Cited by 6
Xiao, B., Xiang, Q., Deng, Z., Chen, D., Wu, S., Zhang, Y., Liang, Y., Shi, W., Luo, G., & Li, L. (2023) · Carcinogenesis · doi:10.1093/carcin/bgad070 · Cited by 5
Framework Nucleic Acids: Innovative Tools for Cellular Sensing and Therapeutics
Zhang, Y., Li, Y., Fang, B., Du, Y., & Peng, P. (2024) · ChemBioChem · doi:10.1002/cbic.202400810 · Cited by 5
Functional nucleic acid-based fluorescence imaging for tumor microenvironment monitoring: A review
Liang, Z., & Tian, F. (2025) · Analytica Chimica Acta · doi:10.1016/j.aca.2025.343794 · Cited by 5
Liu, D., Zhang, T., Sun, Q., Cai, D., Lou, Y., Wang, G., Xie, B., Zhu, Y., Wang, C., Lu, Z., et al. (2025) · Science China Life Sciences · doi:10.1007/s11427-025-2958-3 · Cited by 5
“…+ TCF-1 + CD8 + T cells exhibit stem-like features, defined by their capacities to self-renew, differentiate, engraft, persist and mediate long-term tumor control (Gattinoni et al., 2012; Hudson et al., 2019; Im et al., 2016; Siddiqui et al., 2019; Utzschneider et al., 2016; Vodnala et al., 2019).”
Xie, Z., Liu, J., Chen, Y., Wang, K., Hong, Z., Li, Y., Liang, L., Bi, J., Jin, Y., Shen, W., et al. (2025) · International Journal of Cancer · doi:10.1002/ijc.70313 · Cited by 5
“13,14 Recent studies revealed that tumor-associated macrophages (TAMs) sense high-potassium microenvironments and adapt metabolically via Kir2.”
Fan, J. J., Erickson, A. W., Carrillo-García, J., Wang, X., Skowron, P., Wang, X., Chen, X., Shan, G., Dou, W., Bahrampour, S., et al. (2025) · Developmental Cell · doi:10.1016/j.devcel.2025.01.001 · Cited by 5
Qian-lan, W., Lu, S., Xu, D., Ma, J., Guo, R., Zhang, L., Tang, L., Shen, Y. H., Shen, C., Wang, J., et al. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03730-5 · Cited by 5
“Cytotoxic T lymphocytes play a pivotal role in the immune response against tumors, exerting their cytotoxic function to eliminate cancer cells [22, 23].”
BackgroundIdentifying the source of tumour-infiltrating T cells
Vodnala, S. K., & Restifo, N. P. (2019) · Nature · doi:10.1038/d41586-019-03670-6 · Cited by 5
Self-citationImmunotherapy: A Potential Approach to Targeting Cancer Stem Cells
Wang, W., Bai, L., Xu, D., Li, W., & Cui, J. (2020) · Current Cancer Drug Targets · doi:10.2174/1568009620666200504111914 · Cited by 7
Bignon, Y., Poindessous, V., Rampoldi, L., Haldys, V., & Pallet, N. (2020) · Biochemical Journal · doi:10.1042/bcj20200699 · Cited by 5
Dissecting the heterogeneity of exhausted T cells at the molecular level
Kagoya, Y. (2022) · International Immunology · doi:10.1093/intimm/dxac016 · Cited by 5
Liu, S., Li, Q., Niu, L., Feng, P., Li, W., Dang, Y., Jia, J., Yuan, G., & Pan, Y. (2025) · Molecular Carcinogenesis · doi:10.1002/mc.23911 · Cited by 4
Sun, D., Hu, D., Wang, J., Peng, J., & Wang, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209996 · Cited by 4
Liu, Y., Yan, Z., Fu, Z., Wu, X., Wang, F., & Yuan, Y. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02809-x · Cited by 5
“Autophagy coupled with histone deacetylation modulates CD8 ⁺ T cell effector function and preserves stemness [87], while EP300 inhibition by aspirin induces autophagy to enhance CD8 ⁺ T cell immunity [88].”
Huang, Z., Shi, X., Yang, Y., Ma, W., Li, H., Jin, Z., Feng, Y., Luo, C., Zheng, L., Du, Z., et al. (2025) · ACS Central Science · doi:10.1021/acscentsci.5c01472 · Cited by 4
Metabolic causal factor of immune cell function and fate in the tumor microenvironment
Noor, F., & Noor, H. (2026) · Bulletin du Cancer · doi:10.1016/j.bulcan.2026.01.008 · Cited by 4
Liu, K., Chen, E., Liang, J., Li, Y., Cheng, B., Shi, W., Zhou, Z., Zhou, W., Tian, H., Yang, D., et al. (2025) · Molecular and Clinical Oncology · doi:10.3892/mco.2025.2871 · Cited by 4
“…the marker of stem‑like T cells, and IL7R + CD4 + stem‑like T cells are able to differentiate into Th1, Th2 and other effector cell subpopulations, thereby promoting the effector differentiation of CD8 + T cells through secreting cytokines (such as IFN‑ γ ) and enhancing antitumor immu‑ nity (28).”
Zhang, F., Qi, C., Yao, Z., Xu, H., Zhou, G., Li, C., & Xia, H. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01887-5 · Cited by 4
“However, a previous study reported that necrotic cancer cells secrete a large amount of potassium, which inhibits the activity of CD4 + and CD8 + T cells, thereby blocking the anti-tumor immunity of melanoma [54].”
BackgroundPeng, R., Huang, Q., Wang, L., Qiao, G., Huang, X., Jiang, J., & Chu, X. (2024) · Angewandte Chemie · doi:10.1002/ange.202402715 · Cited by 6
Nanotechnology enabled metal-ion-based disease diagnostics
Lin, P., Lee, J., Chen, Y., Li, F., & Ling, D. (2020) · 中国科学通报:英文版 · doi:10.1016/j.scib.2020.06.006 · Cited by 4
“Furthermore, the excessive release of K by perishing tumor cells causes significant inhibition of T cells in antitumor immunity, accelerating the growth of tumor [5].”
BackgroundXu, Z., Han, Q., Yang, D., Li, Y., Shang, Q., Liu, J., Li, W., Xu, H. Y., & Chen, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.942945 · Cited by 4
“By keeping the T cells in this state, the tumor can avoid being attacked and continue to grow (36).”
BackgroundEnvironmental insults and compensative responses: when microbiome meets cancer
Nagpal, S., & Mande, S. S. (2023) · Discover Oncology · doi:10.1007/s12672-023-00745-9 · Cited by 4
“This includes (i) the neutralization of oxidative stress by microbes in the tumor microenvironment, thereby lowering the compensative load on tumor cells which are also sensitive to redox imbalance [5, 88] (ii) acid stress management by microbial urease system leading to the formation of normally cytotoxic, proinflamm…”
BackgroundPutting the K+ in K+aloric Restriction
Lien, E. C., Lau, A. N., & Heiden, M. G. V. (2019) · Immunity · doi:10.1016/j.immuni.2019.04.016 · Cited by 4
Feeder-free advances in T cell development and therapy
Zhu, E., Liu, Z., & Li, Y.-R. (2025) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100244 · Cited by 3
Vitamin B6 preserves the stemness-like phenotypes and antitumor ability of CD8+ T cells
Wu, J., Li, G. L., Zhou, J., Sun, X., Wang, H., Gong, H., & Jiang, P. (2025) · Developmental Cell · doi:10.1016/j.devcel.2025.10.017 · Cited by 5
Fatty acid metabolism—an emerging regulatory node in T‐cell immunometabolism
Arenberg, B. C., Sack, M. N., & Wu, J. (2026) · Clinical & Translational Immunology · doi:10.1002/cti2.70091 · Cited by 3
Guillemette, A., Gez, E., Titah, S., & Touil, Y. S. (2026) · Journal of Immunology Research · doi:10.1155/jimr/5768926 · Cited by 3
Li, Q.-Q., Wu, H., (12946), Y. Z., & Ma, M. (2026) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2026.218165 · Cited by 3
CAR T-Cell Therapy in Solid Tumors: Current Review and Future Perspectives
Zheng, J. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v54i.9841 · Cited by 4
DIALing-up the preclinical characterization of gene-modified adoptive cellular immunotherapies
Torchia, M. L. G., & Moody, G. E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1264882 · Cited by 3
Singh, A., Choudhury, S. D., Singh, P., Singh, V. V., Singh, S. N., & Sharma, A. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.110256 · Cited by 3
Zhou, J., You, D., Chen, M., Chen, X., Wang, S., Peng, B., Lange, T., Ma, H., Shen, H., Chen, F., et al. (2025) · The Innovation Medicine · doi:10.59717/j.xinn-med.2025.100124 · Cited by 3
He, S., Fan, T., Zhang, Y., Wei, C., Chen, Z., Shi, Y., & Hu, J. (2022) · ChemNanoMat · doi:10.1002/cnma.202200453 · Cited by 3
JIN, L., CHEN, H., RUAN, Q., LIU, R., FAN, Y., XU, X., WANG, D., & Lü, J. (2023) · Biocell · doi:10.32604/biocell.2023.028457 · Cited by 3
Zhu, H., Gao, X., Wang, B., Niu, B., Liu, D., Zhang, J., Jin, Y., & Yang, X. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123248 · Cited by 3
Molecular signaling and clinical implications in the human aging-cancer cycle
Rezaeian, A.-H., & Wei, W. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.08.003 · Cited by 3
Chen, G., Yuan, L., Zhang, Y., Li, T., You, H., Han, L., Qin, P., Wang, Y., Liu, X., Guo, J., et al. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102138 · Cited by 3
“Vodnala et al. [28] demonstrated that T cells exposed to increased extracellular potassium levels ( ↑ [ K + ] e ) exhibited decreased IFN-γ , pre-served IL-2 production, and displayed stem cell-like characteristics.”
BackgroundResultSelf-citationZhou, J., Bai, J., Yue, Y., Chen, X., Lange, T., You, D., & Zhao, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.757456 · Cited by 3
Rivera, G. O. R., Dwyer, C. J., Knochelmann, H. M., Smith, A. S., Aksoy, A., Cole, A. C., Wyatt, M. M., Thaxton, J. E., Lesinski, G. B., & Paulos, C. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.08.531589 · Cited by 4
“We next assessed if idelalisib expanded T cells functioned like stem-like memory cells, which express 241 Tcf-1 and Lef-1, proliferate, and co-secrete cytokines (21, 22).”
BackgroundPKM2, the “K+ sink” in the tumor interstitial fluid
Na, W., Zeng, W., Song, K., Wang, Y., Wang, L., Zhao, Z., Jin, L., Zhu, P., & Liang, W. P. (2024) · Protein & Cell · doi:10.1093/procel/pwae036 · Cited by 2
“thereby tilting the immune landscape toward a suppressive state (Eil et al., 2016; Vodnala et al., 2019).”
Li, Q., Wang, L., Xie, W., Tan, Q., Zhou, S., Pei, H., Zhang, H., Li, J., Qu, F., & Tan, W. (2025) · Angewandte Chemie · doi:10.1002/ange.202505223 · Cited by 2
Delving Into the Dialogue between Epigenetic Modifications and Immunometabolism in Cancer
Xie, X., Liu, W. L., Zhang, Z., Luo, P., Tang, B., & Mao, W. (2025) · Advanced Genetics · doi:10.1002/ggn2.202500034 · Cited by 2
Komori, S., Komada, T., Matsumura, T., Karasawa, T., Miura, Y., Baatarjav, C., Gunji, Y., Aizawa, H., Mizushina, Y., Fukushima, N., et al. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.08.010 · Cited by 2
Fu, X., Zhu, Y., Lu, X., Gao, X., Xin, L., Ren, Y., Liu, X., Ge, L., Hao, J., Yao, Z., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08300-w · Cited by 3
“Collectively, these results indicate that ACSS1 participates in histone acetylation dynamics in response to DNA damage, thereby promoting error-free HR-mediated DNA repair.”
Self-citationPotassium ion homeostasis modulates mitochondrial function
Waite, A. J., Rao, B., Schinski, E. L., Thayer, N. H., Hotz, M., Lefebvre, A. E. Y. T., Sandoval, C. M., & Gottschling, D. E. (2025) · The Journal of Cell Biology · doi:10.1083/jcb.202505110 · Cited by 2
“For instance, the high potassium tumor microenvironment can lead to suppression of T cell effector functions and their ability to differentiate (Vodnala et al., 2019).”
Zhang, F., Dong, C., Chow, R. D.-W., Xin, S., He, E., Feng, Y., Zhu, L., Mirza, D., Tian, X., Yang, L., et al. (2026) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-0545 · Cited by 5
Chen, F., Liu, X., Zhang, Y., Zheng, Y., Yang, J., Wu, T., Zhao, K., Chen, W., Li, Y., Gong, X., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70529-6 · Cited by 2
“Thesemarkersre fl ectabnormalmetabolicactivity and facilitate the differentiation between tumor and normal tissues 40 – 44 .”
Self-citationYang, L., Sheng, J., Qi, S., Yin, Z., Chan, M., Cao, Y., Zhao, H., Wan, Z., Chan, B., Ahn, J. Y., et al. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00943-3 · Cited by 2
“The ability to produce high level of cytokines, such as interferon-γ (IFN-γ), is a key indicator of effector functionality [61] and resistance to exhaustion [62–65].”
Wang, M., Dong, W., Chen, J., Zhou, Z., Fu, S., Wu, T., Jiang, H., Wang, Z., Zhong, Z., & Zhong, Y. (2026) · Advanced Science · doi:10.1002/advs.75651 · Cited by 2
“…mechanisms such as activating the DNA damage response or extreme lipid peroxidation, pushes T cells toward a senescence-like state or programmed cell death, respectively, thereby accelerating T-cell functional decline and impairing the persistence of functional T cells within the tumor [ 75, 76 ].”
Atilla, E. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1863485 · Cited by 2
“It was demonstrated that impaired mitochondrial fi tness and limited metabolic fl exibility accelerate exhaustion under chronic stimulation, a dynamic that is particularly relevant in the nutrient-restricted, hypoxic marrow of AML (17 – 19).”
Targeting lysosome-dependent cell death in cancer: towards therapeutic strategies
Li, Y., Feng, J., Dong, X., Yuan, Z., Zheng, L.-L., Zhang, L., & Wang, L. (2026) · Biomarker Research · doi:10.1186/s40364-026-00969-1 · Cited by 2
“Although heightened autophagy triggers metabolic and epigenetic remodeling that suppresses T cell effector functions, it preserves capabilities such as self-renewal, expansion, and multipotency, preventing T cell exhaustion and overall suppressing tumor progression [211].”
NAMPT beyond NAD+ biosynthesis: roles in tumor microenvironment remodeling and cancer progression
Sun, W.-D., Bi, S.-Z., Zhu, X., Lai, S.-Y., Zhang, C., Liu, A., & Li, J.-H. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118344 · Cited by 2
The emerging cellular metal ions–immune axis in cancer
Qin, S., Xiang, M., Tao, T., Liu, S., Xiao, D., & Tao, Y. (2026) · Trends in Cell Biology · doi:10.1016/j.tcb.2026.08.013 · Cited by 2
Hyperosmolar Potassium Inhibits Corneal Myofibroblast Transformation and Prevent Corneal Scar
Liao, K., Cui, Z., Wang, Z., Yu, P., Tang, S., & Chen, J. (2022) · Current Eye Research · doi:10.1080/02713683.2022.2129072 · Cited by 2
Yassin‐Kassab, A., Wang, N. S., Foley, J. R., Stewart, T. M., Burns, M. R., Casero, R. A., Harbison, R. A., & Duvvuri, U. (2023) · Oral Oncology Reports · doi:10.1016/j.oor.2023.100123 · Cited by 2
Ni, R., Fan, L., Wang, H., Zhang, Q., Zhang, L., Wang, A., Wang, A., & Liu, B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33755 · Cited by 2
“One study showed that inducing autophagy improved the overabundance of potassium in the tumor microenvironment by enhancing tumor clearance CD8 + T cells [35].”
BackgroundThe predictive role of the total potassium intake and odds of breast cancer: a case-control study
Ahmadirad, H., Norouzzadeh, M., Teymoori, F., Jahromi, M. K., Farhadnejad, H., Babrpanjeh, M., Mokhtari, E., Heidari, Z., Mirmiran, P., & Rashidkhani, B. (2024) · BMC Cancer · doi:10.1186/s12885-024-12769-7 · Cited by 3
“Elevated extracellular potassium concentrations lead to increased intracellular potassium in T-cells, impairing receptor phosphorylation and significantly suppressing T-cell effector function [44, 45].”
BackgroundMitochondria in T‑cell tumor immunity and tumor therapies targeting mitochondria (Review)
Zhou, M., Xie, Y., Liu, Z., He, Y., Yin, Y., Chen, K., Zhao, Z., Zhang, C., & Cai, D. (2026) · Oncology Reports · doi:10.3892/or.2026.9064 · Cited by 2
“These pathways control the polariza‑ tion of different types of immune cells, inducing metabolic dysregulation that leads to the loss of antitumor immune responses (14,15).”
Epigenetic programming of the immune responses in cancer
Saadey, A. A., Yousif, A., & Ghoneim, H. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823397-9.00007-7 · Cited by 2
Autophagy in the Immunosuppressive Perivascular Microenvironment of Glioblastoma
Molina, M. L., García‐Bernal, D., Martínez, S., & Valdor, R. (2020) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pacr.1.2020.18 · Cited by 2
Corría-Osorio, J., Carmona, S. J., Stefanidis, E., Andreatta, M., Muller, T., Ortiz-Miranda, Y., Seijo, B., Castro, W., Jiménez‐Luna, C., Scarpellino, L., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.18.481059 · Cited by 2
“cell conditioning in vitro during culture have been proposed as approaches to enhance cell persistence and the efficacy of ACT (Vodnala et al. 2019; Crompton, Sukumar, and Restifo 2014).”
BackgroundMethodInducing an oxidized redox-balance improves anti-tumor CD8 + T cell functionPreprint
Oh, J. H., Cederberg, R. A., Tanaka, E., Bopp, L., Ser, T., Niyyati, S., Patterson, A. E., Amanat, N., Dutra, J., Ye, P., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.27.533229 · Cited by 2
Folz, J., Eido, A., Gonzalez, M. E., Caruso, R., Wang, X., Kleer, C. G., & Jo, J. (2025) · Sensors · doi:10.3390/s25154724 · Cited by 1
“Such elevated K + levels have been shown to suppress T-cell effector functions and impair immune surveillance [8,10], indicating that K + accumulation in the TME may serve as a mechanism by which tumors evade the host immune response.”
Intracellular Dynamic Supramolecular Polymerization to Elicit Tumor Pyroptosis
Wang, Q., Zheng, J., Rong, L., Hua, K., Chen, Y., Liu, J., Li, Y., Zhang, J., Du, Y., & Li, W. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c08932 · Cited by 1
A DNA-Programmed Potassium Ion Magnetic Resonance Sensor
Liang, Z., Liu, X., Zhang, B., Du, H., Zheng, J., Li, F., & Ling, D. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c22582 · Cited by 1
Self-citationDietary intervention & immunity: underlying mechanisms and future directions
Zhao, J., Li, X., Liang, Y., Dai, T., Chen, C., Guo, M., Zhao, X., & Xu, L. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.03.026 · Cited by 1
Chirality-Driven Immune Checkpoint Modulation by Chiral Iridium(III) Nanoparticles
Zhu, L., Wen, Z., Yu, M., Zhang, J., Qin, Y., Gao, S., Mao, Y., Deng, Y., Tian, T., Liu, S., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c00020 · Cited by 1
Wang, X., Liu, X., Wu, G., Wang, H., Yu, K., Liu, Y., Xu, H., Sun, X., An, Z., Zhao, L., et al. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-026-05083-5 · Cited by 1
“Given that existing studies have shown that elevated extracellular K ⁺ concentration can trigger a starvation response in T cells, leading to autophagy [29], we examined the effect of extracellular K ⁺ on the overall autophagic activity of NK cells.”
Self-citationIonic regulation of cancer cell stiffness and metastatic colonization via the MRTFA-KCNMB1 axis
Gajda, A. M., Haloul, M., Pai, V., Mollaeian, K., Patel, K. J., Rodríguez-López, R., Beverley, K., Sanborn, M. A., Lee, K., Castillo, C. C., et al. (2026) · Developmental Cell · doi:10.1016/j.devcel.2026.05.001 · Cited by 1
Fan, H., Li, X., Song, H., Zhang, S., Tian, Z., Chen, Y., Zhou, J., Geng, S., Liu, H., Wang, Y., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124406 · Cited by 1
Liu, Y., Du, W., & Deng, W. (2026) · International Reviews of Immunology · doi:10.1080/08830185.2026.2687543 · Cited by 1
Low-dose docetaxel reprograms CAR T cells for enhanced solid tumor immunity
Zhu, S., Yin, J., Fu, X., Yang, W., Zeng, Y., Chen, R., Huang, N., Zhang, L., Yu, C., Huang, Q., et al. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-026-03781-9 · Cited by 1
“3C, D) [19, 20].”
The pentose phosphate pathway in immunotherapy
Loo, R. D., & Blazeck, J. (2026) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiag106 · Cited by 1
CD5 + dendritic cell robots mediated in situ immunocyte activation
Li, C., Zhang, W., Chen, X., Ding, S., Wang, L., Wang, Q., Yu, S., Zhu, Q., Niu, J., Cui, Y., et al. (2026) · Science Advances · doi:10.1126/sciadv.aee5305 · Cited by 1
The electrical tumor microenvironment: abnormalities and opportunities
Burchett, A. A., Lay, F., & Datta, M. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1870705 · Cited by 1
“The characteristic necrotic core of solid tumors releases potassium ions into the extracellular space, which impairs T cell activation through the T cell receptor and effector function, which can be rescued by increasing potassium ef fl ux (110, 111).”
Kleiman, E., Ouerkaxi, W., Delcommenne, M., Stone, G. W., Serafini, P., Tleugabulova, M. C., & Daftarian, P. M. (2020) · Methods in pharmacology and toxicology · doi:10.1007/978-1-0716-0171-6_5 · Cited by 1
Embí, A. A. (2021) · International Journal of Research -GRANTHAALAYAH · doi:10.29121/granthaalayah.v9.i9.2021.4260 · Cited by 1
“International Journal of Research - GRANTHAALAYAH 81 Perhaps some elucidation could be explained by findings where a link between tumor-induced immune suppression by the Potassium ion (K+) exists (Vodnala et al. (2019)).”
BackgroundProgress in functional characterization of cGAS
Wang, Z., Zhao, M., & HaiPeng, L. I. U. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0404 · Cited by 1
[Advances in Research on Cell Metabolic Interactions in the Tumor Microenvironment].
Wu, P., Yang, Z., Li, Q., & Wang, D. (2024) · PubMed Central · doi:10.12182/20240360606 · Cited by 4
Frontiers of Cancer Diagnostics: From Photoacoustic Chemical Imaging to Cellular Morphodynamics
Folz, J. (2020) · Deep Blue (University of Michigan) · Cited by 1
Wang, D., Yu, W., Wang, Z., Yu, X., Chi, Z., Zhang, K., Chen, S., Xu, T., Jiang, D., Guo, X., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-85111/v1 · Cited by 1
“Augmenting K+ e ux in tumor-speci c T cells improves effector functions and enhances tumor clearance and survival (Eil et al., 2016), while exposure to increased [K+]e enhances the persistence and anti-tumor function of T cells (Vodnala et al., 2019).”
BackgroundKeshavarz‐Fathi, M., Keshavarz-Fathi, M., & Rezaei, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00083-5 · Cited by 1
CD8+ T cells pass the acid test
Oh, J. H., Archambault, A., & Geltink, R. I. K. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00738-6 · Cited by 1
Metadata
- Authors
- Vodnala, S. K., Eil, R., Kishton, R. J., Sukumar, M., Yamamoto, T. N., Ha, N.-H., Lee, P.-H., Shin, M., Patel, S. J., Yu, Z., Palmer, D. C., Kruhlak, M. J., Liu, X., Locasale, J. W., Huang, J., Roychoudhuri, R., Finkel, T., Klebanoff, C. A., & Restifo, N. P.
- Affiliations
- National Institutes of Health (US)
- National Cancer Institute (US)
- Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
- Duke University (US)
- Babraham Institute (GB)
- University of Pittsburgh (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Vodnala, Suman Kumar
- Eil, Robert
- Restifo, Nicholas P.
- ORCID
- Vodnala, Suman Kumar
- Eil, Robert
- Kishton, Rigel J.
- Sukumar, Madhusudhanan
- Yamamoto, Tori N.
- Ha, Ngoc-Han
- Lee, Ping-Hsien
- Shin, MinHwa
- Patel, Shashank J.
- Yu, Zhiya
- Palmer, Douglas C.
- Kruhlak, Michael J.
- Liu, Xiaojing
- Locasale, Jason W.
- Huang, Jing
- Roychoudhuri, Rahul
- Finkel, Toren
- Klebanoff, Christopher A.
- Restifo, Nicholas P.
- Venue
- Science
- Published
- 2019-03-29
- Volume
- 363
- Issue
- 6434
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC8194369
- OpenAlex
- W2924300946
- Cited by
- 552
- References
- 49
- Citations by year
- 2026: 55 · 2025: 77 · 2024: 78 · 2023: 70 · 2022: 86 · 2021: 76 · 2020: 73 · 2019: 36
- FWCI
- 27.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Cancer Society (129832-RSG-16-214-01-TBE)
- National Cancer Institute (P30 CA008748)
- NIH Clinical Center
- Damon Runyon Cancer Research Foundation
- Parker Institute for Cancer Immunotherapy
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- T cell stemness, T cell dysfunction, tumor microenvironment, potassium ions, T cell metabolism, nutrient uptake, autophagy, acetyl-CoA, T cell exhaustion, antitumor immunity, tumor immune evasion
- MeSH terms
- Acetyl Coenzyme A, Acetylation, Animals, Autophagy, Cell Differentiation, Histones, Humans, Immune Tolerance, Lymphocyte Activation, Mice, Inbred C57BL, Neoplasms, Potassium, Stem Cells, Lymphocytes, Tumor-Infiltrating, CD8-Positive T-Lymphocytes, Caloric Restriction, Epigenesis, Genetic, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.